Priority Date: 28.06.12 (PT 20130121064)

THE USE OF RET AGONIST MOLECULES FOR HAEMATOPOIETIC STEM CELL EXPANSION PROTOCOLS AND TRANSPLANTATION THERAPY AND A RET AGONIST KIT

  • Application ID: EP13767077
  • Status: EXAMINATION IN PROGRESS

Attorney

operating since 1879
Headquarter in Madrid and 31 offices
active in Legal Services and IP Consulting

Specialization

This EP application has the IPC combination A01, A61, and C12. Clarke, Modet & Co is specialized in the combination A01, A61, and C12. We found, that Kailuweit & Uhlemann, Sperling Fischer & Heyner, Lederer Keller Patentanwälte Partnerschaft mbB, Uexküll & Stolberg Partnerschaft von Patent- und Rechtsanwälten mbB, Vereenigde Octrooibureaux NV (V.O.) and 37 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 28.06.2012 - Priority Date (PT 20130121064)
  • 03.01.2014 - Publication A1 (WO2014002038)
  • 20.05.2015 - Publication A1 (EP2872622)